Feature | October 30, 2008| Nick Obradovich

Is Coronary MR Angiography Ready for Prime Time?

Despite some key advantages, MRA is not yet expected to overtake coronary CTA.

The University of Virginia Health System uses a Siemens MAGNETOM Avanto 1.5T MRI system.

The University of Virginia Health System uses a Siemens MAGNETOM Avanto 1.5T MRI system.

"Potential” can be a loaded word, especially in healthcare. Many clinicians have tagged coronary MR angiography (MRA) with the “potential” label. Despite the scan’s reported safety advantages over coronary CT angiography (CTA), as well as its superior physiologic information, coronary MRA has not gained the widespread acceptance of coronary CTA.

Yet, many clinicians are hopeful the scan will gain momentum in the coming years as new techniques and new hardware/software progress.

What is the Potential?

Many cardiologists and radiologists are excited about the potential for coronary MRA to evaluate plaque. MR has been able to see and evaluate plaque for years in the carotid, aortic and peripheral arteries, according to Warren Manning, M.D., professor of radiology at Harvard Medical School, member of the cardiovascular disease department at Beth Israel Deaconess Medical Center in Boston. However, this potential has not led to significant clinical applications for coronary MRA for a large patient population.

“Plaque in coronary arteries is far more complicated in the MR,” Dr. Manning said. “The coronary wall is even smaller than the coronary lumen, so the burdens are more strict with motion compensation. There are techniques using gadolinium looking at inflammation in the wall of the arteries.

“CT looks at the anatomy. Is there a calcified plaque or a soft plaque? MR is looking for any plaque or if there is inflammation in the wall. We think inflammation probably means someone is at an increased risk for plaque rupture, but at the present time it’s just a hypothesis. We don’t really know for sure that MRI can identify the sites where plaque will rupture. All of this for [MR] coronary plaque imaging is really in the research arena at the present time.”

Safety, Imaging Advantages

Currently, coronary MRA’s primary advantage over CTA is that it doesn’t use radiation or iodinated contrast material.
“One of the issues that often comes up is if patients are going to need repeated studies,” Dr. Manning said. “Repeated studies in the CT world mean repeated exposure to radiation. There are no such issues with MR.”

Many doctors, as well as parents, are hesitant to expose children to radiation from a CT scan. For this reason, coronary MRA is preferred for younger patients being imaged for anomalous coronary artery disease, according to an American Heart Association Scientific Statement released in July.

“If one isn’t trying to discriminate ischemic versus non-ischemic cardiomyopathies, then I think both MR and CT work, and we’d say that MR may be preferred in that group as well,” Dr. Manning said.

Coronary MRA doesn’t typically use contrast, while CTA uses iodine-based contrast materials that can be problematic for patients with renal insufficiencies.

The scan also holds advantages over CTA in that it doesn’t require a slow heartbeat and it images calcium better. Heavily calcified arteries are a burden for CTA. However, in part because the MR allows for free breathing, a coronary MRA has an acquisition time of 5-10 minutes, as opposed to less than 20 seconds for a CTA.

Spatial Resolution vs. CTA

The major drawback to coronary MRA is the inferior spatial resolution, according to Christopher M. Kramer, M.D., professor of radiology and medicine, director of cardiovascular imaging, University of Virginia Health System.

“Because CT has higher spatial resolution and has performed better for stenosis detection, CTA is preferable,” Dr. Kramer said. “For many other cardiac applications, MR is preferable. In 2008, for assessment of coronary artery disease in a middle- aged or older patient, CT is probably preferable.”

Dr. Manning believes that although CTA has better spatial resolution, a coronary MRI scan is still very readable.

“If you have experience [in reading both scans], then I think the interpretation is similar,” Dr. Manning said. “I think there are more 64-slice CT scanners in existence than there are MR sites that have experience in coronary MRI. People need to consider their local expertise like every other imaging or procedural modality.”

Coronary MRI has improved in recent years, according to Dr. Kramer, who has used Siemens’ MAGNETOM Avanto 1.5T MRI system since 2004.

“The major improvements have been the use of 3D coronary imaging,” Dr. Kramer said. “This is a 3D whole-heart approach where a navigator is used to track diaphragmatic motion and capture the 3D image of the heart over many heart beats. It’s respiratory-gated using navigator echoes. The improvement in the navigators has also helped image quality.”

Dr. Manning, who uses a Philips 1.5T MRI system, also noted scanners have moved from 16 to 32 channel coils, which helps with signal-to-noise ratios.

New Technology, Techniques

There is no shortage of ways in which clinicians are looking to improve spatial resolution to help coronary MRA reach its potential.

“Going to 3 Tesla has the potential to improve image quality and spatial resolution for certain applications,” Dr. Kramer said. “Coronary imaging is one of them. There’s certainly more data coming out now with whole-heart coronary angiography MR at 3T. I think the performance will be better than at 1.5T, but still not to CTA spatial resolution.”

Dr. Manning noted than MR can yield better results without having a hardware upgrade.

“MR advances are very much software-based,” Dr. Manning said. “New algorithms to do something. New sequences. But, you’re still using the same 1.5T or 3T scanner. That’s another advantage of MR.”

Other solutions to the spatial resolution problem include using a gadolinium-based contrast for the coronaries, using an intravascular MRI or developing the scan on higher field MR system.

“There is some work on intravascular MRI, but that’s invasive and not useful for a general patient population screening,” Dr. Kramer said. “There are 7T scanners scattered around the world, but there are a lot of issues to be tackled when you go to that high of a field.

“There is a potential to use MR contrast in imaging the coronary arteries,” he said. “It’s a little difficult because it’s a long acquisition, so the timing of contrast infusion relative to the acquisition of the images is tricky, but it may enhance coronary imaging.”

Related Content

News | Cardiac Diagnostics| February 17, 2017
Levels of a protein in the blood associated with heart disease are also linked to early-stage brain damage, according...
Siemens Healthineers, Magnetom Sempra MRI system, FDA approval, RSNA 2017
Technology | Magnetic Resonance Imaging (MRI)| February 17, 2017
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sempra 60-cm 1...
GE Healthcare, GSI Xtream, FDA clearance, spectral CT, Revolution, RSNA 2017, SCCT
Technology | Computed Tomography (CT)| February 15, 2017
February 15, 2017 — GE Healthcare announced U.S.
HeartFlow FFRct Analysis, NICE guidance, U.K., United Kingdom, guidelines, stable chest pain
News | CT Angiography (CTA)| February 14, 2017
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of...
Sir Peter Mansfield, early MRI trials, obituary, University of Nottingham

Sir Peter Mansfield during the original MRI trials. Image courtesy of the University of Nottingham.

Feature | Magnetic Resonance Imaging (MRI)| February 09, 2017 | Jeff Zagoudis
February 9, 2017 — Sir Peter Mansfield, FRS, whose research aided the development of...
GE Healthcare, Rapiscan stress imaging agent, North America, Rapidscan Pharma Solutions Inc.
News | Pharmaceuticals| February 07, 2017
GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma Solutions Inc., which has...
GE Healthcare, Freelium technology, MRI magnet cooling, RSNA 2016, RSNA 2017
News | Magnetic Resonance Imaging (MRI)| February 06, 2017
At the 2016 Radiological Society of North America (RSNA) annual meeting, GE Healthcare unveiled Freelium, a magnet...
Technology | Advanced Visualization| February 06, 2017
February 6, 2017 — At the Society of Cardiac Magnetic Resonance (SCMR) 20th Annual Scientific Sessions, GE Healthcare
CT, computed tomography, IV contrast media, acute kidney injury risk, Annals of Emergency Medicine study

A new study in Annals of Emergency Medicine finds no association between intravenous contrast media used in computed tomography (CT) and kidney damage. Roughly 80 million doses of IV contrast media are given every year. Credit: American College of Emergency Physicians

News | Contrast Media| January 30, 2017
Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be...
blood pressure, gray zone, hypertension, personalized treatment, Circulation journal study, CT calcium scores
News | Hypertension| January 23, 2017
Using data from a national study, Johns Hopkins researchers determined that using heart computed tomography (CT) scans...
Overlay Init